Gene · 3046
Papers4,524
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 4,524
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 12th ISNS European Regional Meeting Oral and Poster Abstracts. | Int J Neonatal Screen | 2021 | 34842605 | PubTator, text mining | PubMed |
| The Alberta Newborn Screening Approach for Sickle Cell Disease: The Advantages of Molecular Testing. | Int J Neonatal Screen | 2021 | 34842602 | PubTator, text mining | PubMed |
| In Vivo Bioluminescence Imaging of HBV Replicating Hepatocytes Allows for the Monitoring of Anti-Viral Immunity. | Viruses | 2021 | 34835079 | PubTator, text mining | PubMed |
| Sickle Cell Anemia and Babesia Infection. | Pathogens | 2021 | 34832591 | PubTator, text mining | PubMed |
| Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based Therapies. | Cells | 2021 | 34831472 | PubTator, text mining | PubMed |
| A Novel Algorithm Using Cell Population Data (VCS Parameters) as a Screening Discriminant between Alpha and Beta Thalassemia Traits. | Diagnostics (Basel) | 2021 | 34829510 | PubTator, text mining | PubMed |
| Prediction of Non-canonical Routes for SARS-CoV-2 Infection in Human Placenta Cells. | Front Mol Biosci | 2021 | 34820418 | PubTator, text mining | PubMed |
| Rapid molecular diagnostics of large deletional β0-thalassemia (3.5 kb and 45 kb) using colorimetric LAMP in various thalassemia genotypes. | Heliyon | 2021 | 34816050 | PubTator, text mining | PubMed |
| High prevalence of central hypothyroidism among patients with transfusion dependent thalassemia in Hospital Pulau Pinang: A cross sectional study. | Med J Malaysia | 2021 | 34806663 | PubTator, text mining | PubMed |
| Molecular Subclassification Based on Crosstalk Analysis Improves Prediction of Prognosis in Colorectal Cancer. | Front Genet | 2021 | 34804112 | PubTator, text mining | PubMed |
| Age and genotype dependent erythropoietin protection in COVID-19. | World J Stem Cells | 2021 | 34786155 | PubTator, text mining | PubMed |
| The Cancer-Associated Antigens Sialyl Lewisa/x and Sda: Two Opposite Faces of Terminal Glycosylation. | Cancers (Basel) | 2021 | 34771437 | PubTator, text mining | PubMed |
| Host-cell interactions in HBV infection and pathogenesis: the emerging role of m6A modification. | Emerg Microbes Infect | 2021 | 34767497 | PubTator, text mining | PubMed |
| Molecular characterization of hemoglobinopathies and thalassemias in Northern Guangdong Province, China. | Medicine (Baltimore) | 2021 | 34766575 | PubTator, text mining | PubMed |
| Molecular genetics of β-thalassemia: A narrative review. | Medicine (Baltimore) | 2021 | 34766559 | PubTator, text mining | PubMed |
| Achievement of Pre- and Post-Transfusion Hemoglobin Levels in Adult Transfusion-Dependent Beta Thalassemia: Associated Factors and Relationship to Reduction of Spleen Enlargement. | Int J Gen Med | 2021 | 34754224 | PubTator, text mining | PubMed |
| Amino acid residues at core protein dimer-dimer interface modulate multiple steps of hepatitis B virus replication and HBeAg biogenesis. | PLoS Pathog | 2021 | 34752483 | PubTator, text mining | PubMed |
| Evaluation of Microchip-Based Point-Of-Care Device "Gazelle" for Diagnosis of Sickle Cell Disease in India. | Front Med (Lausanne) | 2021 | 34722554 | PubTator, text mining | PubMed |
| Effects of dyslipidemia on E antigen seroconversion of patients with chronic hepatitis B treated by nucleoside (acid) analogs. | Lipids Health Dis | 2021 | 34717643 | PubTator, text mining | PubMed |
| Genetic and Epigenetic Therapies for β-Thalassaemia by Altering the Expression of α-Globin Gene. | Front Genome Ed | 2021 | 34713267 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3046/papers?page=43